levodopa has been researched along with berberine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, LJ; Guo, X; Jin, GZ; Wang, QM | 1 |
| Wei, D | 1 |
| Le, W | 1 |
| Jin, GZ; Li, JH; Wang, XL; Yu, LP | 1 |
| Jin, GZ; Mo, J; Sun, PH; Yu, LP; Zhang, H; Zhen, X | 1 |
| Choi, HS; Choi, SO; Kwon, IH; Lee, MK; Shin, KS; Suh, KH; Zhao, TT | 1 |
| Cao, X; Cong, L; Fu, J; Gao, TL; Han, P; Jiang, JD; Li, XY; Lin, Y; Ma, SR; Pan, LB; Peng, R; Shou, JW; Tong, Q; Wang, Y; Wen, BY; Yu, H; Yu, JB; Zhang, XF; Zhang, ZW; Zhao, ZX | 1 |
1 trial(s) available for levodopa and berberine
| Article | Year |
|---|---|
[Clinical study on the treatment of dyskinesia by L-stepholidine].
Topics: Aged; Berberine; Berberine Alkaloids; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Middle Aged; Movement Disorders; Multicenter Studies as Topic; Tourette Syndrome | 1989 |
6 other study(ies) available for levodopa and berberine
| Article | Year |
|---|---|
[Feed-back regulation of presynaptic D2 receptors blockaded by l-stepholidine and l-tetrahydropalmatine].
Topics: Alkaloids; Animals; Apomorphine; Berberine; Berberine Alkaloids; Corpus Striatum; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Levodopa; Male; Rats; Rats, Sprague-Dawley; Stereoisomerism | 1992 |
[Different effects on dopamine receptors D1 and D2 following long-term usage of L-dopa].
Topics: Animals; Behavior, Animal; Berberine; Corpus Striatum; Levodopa; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior; Substantia Nigra | 1991 |
[Effect of tetrahydroberberine on blockade of pre- and postsynaptic dopamine receptors (author's transl)].
Topics: 4-Butyrolactone; Animals; Apomorphine; Berberine; Berberine Alkaloids; Corpus Striatum; Hypnotics and Sedatives; Levodopa; Rats; Receptors, Dopamine | 1982 |
L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antiparkinson Agents; Antipsychotic Agents; Benzazepines; Berberine; CHO Cells; Corpus Striatum; Cricetinae; Cricetulus; Disease Models, Animal; Dopamine Agents; Drug Administration Schedule; Drug Interactions; Dyskinesias; Gene Expression Regulation; Levodopa; Male; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; RNA, Messenger; Serotonin Receptor Agonists; Transfection; Tritium | 2010 |
Neurotoxic effects of berberine on long-term L-DOPA administration in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Berberine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Levodopa; Male; Neurons; Neurotoxicity Syndromes; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Substantia Nigra; Time Factors | 2013 |
Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota.
Topics: Animals; Berberine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Enterococcus faecalis; Enterococcus faecium; Gastrointestinal Microbiome; Humans; Levodopa; Mice; Parkinson Disease; Tyrosine 3-Monooxygenase | 2021 |